MedPath

Effect of tranexamic acid on postpartum hemorrhage.

Phase 2
Conditions
Condition 1: hemorrhage following delivery. Condition 2: hemorrhage following delivery. Condition 3: hemorrhage following delivery. Condition 4: complications after delivery. Condition 5: hemorrhage following delivery.
haemorrhage after delivery of fetus or infant
Third-stage haemorrhage
Complication of labour and delivery, unspecified
Other specified complications of labour and delivery
Other immediate postpartum haemorrhage
Registration Number
IRCT20091023002624N22
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
200
Inclusion Criteria

Pregnant
singleton
gestational age between 37-42 weeks
normal blood pressure (< 140/90 mmHg)
informed consent for the study

Exclusion Criteria

history of coagulopathy
pre-eclampsia
placental abruption
hypersensitivity to tranexamic acid
Body Mass Index(BMI) of more than 30
episiotomy
history of cardiac, hepatic, renal and neurologic disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemoglobin level. Timepoint: At the time of admission and 6 hours after delivery . Method of measurement: blood test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath